Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9,-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide | Patent Publication Number 20150366872
US 20150366872 A1Patent NumberUS 09682084 B2
Application Number14745121
Filled DateJun 19, 2015
Priority DateJun 20, 2014
Publication DateDec 24, 2015
Original AssigneeGilead Sciences
Current AssigneeGilead Sciences
Inventor/ApplicantsErnest A. Carra
Katie Ann Keaton
Vahid Zia
Irene Chen
Scott E. Lazerwith
Katie Ann Keaton
Vahid Zia
Irene Chen
Scott E. Lazerwith
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.